Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Island Pharmaceuticals (ILA AU)
Watchlist
13
Analysis
Health Care
•
Australia
Island Pharmaceuticals Limited operates as a drug research and repurposing company. The Company focuses on developing preventative or therapeutic drugs for viral infections. Island Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Island Pharmaceuticals
•
18 Jun 2026 08:00
•
Issuer-paid
Island Pharmaceuticals Ltd - A busy month with continued progress
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. June has been a productive month for the...
Research as a Service (RaaS)
Follow
91 Views
Share
bullish
•
Island Pharmaceuticals
•
22 May 2026 09:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Key appointments amidst an Ebola outbreak
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company has made two announcements...
Research as a Service (RaaS)
Follow
114 Views
Share
bullish
•
Island Pharmaceuticals
•
13 Mar 2026 06:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Exploring indication expansion
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company announced on 9 March 2026 a...
Research as a Service (RaaS)
Follow
322 Views
Share
bullish
•
Island Pharmaceuticals
•
10 Mar 2026 09:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Aligning with the US Government
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company announced on 4 March 2026...
Research as a Service (RaaS)
Follow
128 Views
Share
bullish
•
Island Pharmaceuticals
•
06 Feb 2026 06:00
•
Issuer-paid
Island Pharmaceuticals Ltd - Fully funded with regulatory clarity
Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases. The company announced on 4 February 2026...
Research as a Service (RaaS)
Follow
146 Views
Share
Previous
1
2
3
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x